Potential inhibitors isolated from Curcuma aeruginosa against dengue virus type 2 (DENV-2) NS2B-NS3 protease activity

References

• Soni, S., Gill, V.J.S., Anusheel, S.J., Chhabra, J., Gill, G.J.S., Rupinder, B. (2023). Dengue, Chikungunya and Zika: The causes and threats of emerging and re-emerging arboviral diseases. Cureus. (7): e41717.
   PubMed Web of Science ®Google Scholar
• Wiyono, L., Rocha, I.C.N., Cedeño, T.D.D., Miranda, A.V., Lucero-Prisno Iii, D.E. (2021). Dengue and COVID-19 infections in the ASEAN region: A concurrent outbreak of viral diseases. Epidemiol. Health. 43:e2021070. doi: 10.4178/epih.e2021070
   PubMed Web of Science ®Google Scholar
• Messina, J.P., Brady, O.J., Scott, T.W., Zou, C., Pigott, D.M., Duda, K.A., Bhatt, S., Katzelnick, L., Howes, R.E., Battle, K.E., Simmons, C.P., Hay, S.I. (2014). Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol. 22(3):138-146. doi: 10.1016/j.tim.2013.12.011
   PubMed Web of Science ®Google Scholar
• Mustafa, M.S., Rasotgi, V., Jain, S., Gupta, V. (2015). Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Medical Journal Armed Forces India. 71(1): 67-70. doi: 10.1016/j.mjafi.2014.09.011
   PubMedGoogle Scholar
• Normile, D. (2013). Surprising new dengue virus throws a spanner in disease control efforts. Science (Tropical Medicine). 342(6157): 415.
   Google Scholar
• Muller, D.A., Depelsenaire, A.C., Young, P.R. (2017). Clinical and laboratory diagnosis of dengue virus infection. J. Infect. Dis. 215(Suppl 2): S89-S95. doi: 10.1093/infdis/jiw649
   PubMedGoogle Scholar
• Hasan, S., Jamdar, S.F., Alalowi, M., Al Ageel Al Beaiji, S.M. (2016). Dengue virus: A global human threat: Review of literature. J. Int. Soc. Prev. Community Dent. 6(1): 1-6. doi: 10.4103/2231-0762.175416
   PubMed Web of Science ®Google Scholar
• Selvarajoo, S., Liew, J.W.K., Tan, W., Lim, X.Y., Refai, W.F., Zaki, R.A., Sethi, N., Wan Sulaiman, W.Y., Lim, Y.A.L., Vadivelu, J., Vythilingam, I. (2020). Knowledge, attitude and practice on dengue prevention and dengue seroprevalence in a dengue hotspot in Malaysia: A cross-sectional study. Sci. Rep. 10(1): 9534. doi: 10.1038/s41598-020-66212-5
   PubMed Web of Science ®Google Scholar
• Fried, J.R., Gibbons, R.V., Kalayanarooj, S., Thomas, S.J., Srikiatkhachorn, A., Yoon, I.K., Jarman, R.G., Green, S. Rothman, A.L., Cummings, D.A.T. (2010). Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl. Trop. Dis. 4(3): e617. doi: 10.1371/journal.pntd.0000617
   PubMed Web of Science ®Google Scholar
• Ismail, I.S., Hairon, S.M., Yaacob, N.M., Besari, A.M., Abdullah, S. (2019). Usage of traditional and complementary medicine among dengue fever patients in the Northeast region of Peninsular Malaysia. Malays J. Med. Sci. 26(3): 90-101.
   PubMed Web of Science ®Google Scholar
• Thomas, S.J. (2023). Is new dengue vaccine efficacy data a relief or cause for concern? npj Vaccines. 8(1): 55. doi: 10.1038/s41541-023-00658-2
   PubMed Web of Science ®Google Scholar
• Thomas, S.J., Yoon, I.K. (2019). A review of Dengvaxia®: development to deployment. Hum. Vaccin Immunother. 15(10): 2295-2314. doi: 10.1080/21645515.2019.1658503
   PubMed Web of Science ®Google Scholar
• Atanasov, A.G., Zotchev, S.B., Dirsch, the International Natural Product Sciences Taskforce, Supuran, C.T. (2021). Natural products in drug discovery: advances and opportu-nities. Nat. Rev. Drug. Discov. 20(3): 200-216. doi: 10.1038/s41573-020-00114-z
   PubMedGoogle Scholar
• Wei, W., Rasul, A., Sadiqa, A., Sarfraz, I., Hussain, G., Nageen, B., Liu, X., Watanabe, N., Selamoglu, Z., Ali, M., Li, X., Li, J. (2019). Curcumol: From plant roots to cancer roots. Int. J. Biol. Sci. 15(8): 1600-1609. doi: 10.7150/ijbs.34716
   PubMed Web of Science ®Google Scholar
• Al-Amin, M., Eltayeb, N.M., Hossain, C.F., Rahiman, S.S.F., Khairuddean, M., Muhamad Salhimi, S. (2022). Bioactive compounds from Curcuma aeruginosa and the effect of comosone II on the migration and invasion of breast cancer cells. J. Asian Nat. Prod. Res. 25(3): 252-263. doi: 10.1080/10286020.2022.2081562
   Web of Science ®Google Scholar
• Lim, T.K. (2016). Curcuma aeruginosa. Edible medicinal and non-medicinal plants: modified stems, roots, bulbs. Vol. 13, Springer, Berlin. 233-240 p. doi: 10.1007/978-3-319-26065-5_13
   Google Scholar
• Otake, T., Mori, H., Morimoto, M., Ueba, N., Sutardjo, S., Kusumoto, I.T., Hattori, M., Namba, T. (1995). Screening of Indonesian plant extracts for anti-human immunodeficiency virus-type 1 (HIV-1) activity. Phytother. Res. 9: 6-10. doi: 10.1002/ptr.2650090103
   Web of Science ®Google Scholar
• Hossain, C.F., Al-Amin, M., Sayem, A.S.M., Siragee, I.H., Tunan, A.M., Hassan, F., Kabir, M.M., Sultana, G.N.N. (2015). Antinociceptive principle from Curcuma aeruginosa. BMC Complement. Altern. Med. 15(1): 191. doi: 10.1186/s12906-015-0720-6
   PubMedGoogle Scholar
• Cenci, E., Messina, F., Rossi, E., Epifano, F., Marcotullio, M.C. (2012). Antiviral furano-sesquiterpenes from Commiphora erythraea. Nat. Prod. Commun. 7(2): 143-144.
   PubMed Web of Science ®Google Scholar
• He, W., Zhai, X., Su, J., Ye, R., Zheng, Y., Su, S. (2019). Antiviral activity of germacrone against pseudorabies virus in vitro. Pathogens. 8(4): 258 doi: 10.3390/pathogens8040258
   PubMed Web of Science ®Google Scholar
• Feng. J., Bai, X., Cui, T., Zhou, H., Chen, Y., Xie, J., Shi, Q., Wang, H., Zhang, G. (2016). In vitro antiviral activity of germacrone against porcine reproductive and respiratory syndrome virus. Curr. Microbiol. 73(3): 317-323. doi: 10.1007/s00284-016-1042-8
   PubMed Web of Science ®Google Scholar
• Liu, M., Xiao, H., Zhang, Q., Wu, S., Putra, D.F., Xiong, X., Xu, M., Dong, L. Li, S., Yu, Q., Li, P. (2020). Antiviral abilities of Curcuma kwangsiensis ingredients against grouper iridoviral infection in vitro and in vivo. Aquac. Res. 51(1): 351-361. doi: 10.1111/are.14382
   Web of Science ®Google Scholar
• Narayanan, A., Kehn-Hall, K., Senina, S., Lundberg, L., Van Duyne, R., Guendel, I., Das, R., Baer, A., Bethel, L., Turell, M., Hartmann, A.L., Das, B., Bailey, C., Kashanchi, F. (2012). Curcumin inhibits Rift Valley fever virus replication in human cells. J. Biol. Chem. 287(40): 33198-33214. doi: 10.1074/jbc.M112.356535
   PubMed Web of Science ®Google Scholar
• Jani, N.A., Maarof, N.I., Zahari, M.M.F.M., Jamil, M., Zakaria, I.I., Mohamad Zobir, S.Z., Kasim, N., Salin, N.H., Ali, N.A.M., Wan Khalid, W.E.F., Pungot, N.H. (2023). Phytochemical profiling of the essential oils from three Curcuma species and their in vitro and in silico dengue protease inhibition activity. Nat. Prod. Res. 1-7. doi: 10.1080/14786419.2023.2269460
   PubMed Web of Science ®Google Scholar
• Izmirly, A.M., Alturki, S.O., Alturki, S.O., Connors, J., Haddad, E.K. (2020). Challenges in dengue vaccines development: Pre-existing Iinfections and cross-reactivity. Front. Immunol. 11: 1055. doi: 10.3389/fimmu.2020.01055
   PubMed Web of Science ®Google Scholar
• Wahaab, A., Mustafa, B.E., Hameed, M., Stevenson, N.J., Anwar, M.N., Liu, K., Wei, J., Qiu, Y., Ma, Z. et al. (2021). Potential role of flavivirus NS2B-NS3 proteases in viral pathogenesis and anti-flavivirus drug discovery employing animal cells and models: A review. Viruses. 14(1): 44. doi: 10.3390/v14010044
   PubMed Web of Science ®Google Scholar
• Heh, C.H., Othman, R., Buckle, M.J., Sharifuddin, Y., Yusof, R., Rahman, N.A. (2013). Rational discovery of dengue type 2 non-competitive inhibitors. Chem. Biol. Drug. Des. 82(1): 1-11. doi: 10.1111/cbdd.12122
   PubMed Web of Science ®Google Scholar
• Baylan, M., Özcan, B.D., Mazı, G. (2022). Heterologous expression of lichenase gene from Streptococcus bovis in Escherichia coli strain XL1-Blue MRF’. Fresenius Environ. Bull. 31: 5185-5191.
   Web of Science ®Google Scholar
• Yusof, R., Clum, S., Wetzel, M., Murthy, H.M., Padmanabhan. R. (2000). Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J. Biol. Chem. 275: 9963-9969. doi: 10.1074/jbc.275.14.9963
   PubMed Web of Science ®Google Scholar
• Hariono, M., Choi, S.B., Roslim, R.F., Nawi, M.S., Tan, M.L., Kamarulzaman, E.E., Mohamed, N., Yusof, R., Othman, S., Rahman, N.A., Othman, R., Wahab, H.A. (2019). Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling. PLoS One. 14(1): e0210869. doi: 10.1371/journal.pone.0210869
   PubMed Web of Science ®Google Scholar
• Lee, M.F., Wu, Y.S., Poh, C.L. (2023). Molecular mechanisms of antiviral agents against dengue virus. Viruses. 15(3): 705. doi: 10.3390/v15030705
   PubMed Web of Science ®Google Scholar
• Modis, Y., Ogata, S., Clements, D., Harrison, S.C. (2003). A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. USA. 100(12): 6986-6991. doi: 10.1073/pnas.0832193100
   PubMed Web of Science ®Google Scholar
• Erbel, P., Schiering, N., D’Arcy, A., Renatus, M., Kroemer, M., Lim, S.P., Yin, Z., Keller, T.H., Vasudevan, S.G., Hommel, U. (2006). Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat. Struct. Mol. Biol. 3(4): 372-373. doi: 10.1038/nsmb1073
   Google Scholar
• Hassandarvish, P., Rothan, H.A., Rezaei, S., Yusof, R., Abubakar, S., Zandi, K. (2016). In silico study on baicalein and baicalin as inhibitors of dengue virus replication. RSC Advances. 6(37): 31235-31247. doi: 10.1039/C6RA00817H
   Web of Science ®Google Scholar
• Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65(1-2): 55-63. doi: 10.1016/0022-1759(83)90303-4
   PubMed Web of Science ®Google Scholar
• Ulanday, G.E.L., Okamoto, K., Morita, K. (2016). Development and utility of an in vitro, fluorescence-based assay for the discovery of novel compounds against dengue 2 viral protease. Trop. Med. Health. 44(1): 22. doi: 10.1186/s41182-016-0025-6
   PubMedGoogle Scholar
• Rothan, H.A., Han, H.C., Ramasamy, T.S., Othman, S., Rahman, N.A., Yusof, R. (2012). Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1. BMC Infect. Dis. 12(1): 314. doi: 10.1186/1471-2334-12-314
   PubMedGoogle Scholar
• Lin, K.H., Ali, A., Rusere, L., Soumana, D.I., Kurt Yilmaz, N., Schiffer, C.A. (2017). Dengue virus NS2B/NS3 protease inhibitors exploiting the prime side. J. Virol. 91(10): e00045-17. doi: 10.1128/JVI.00045-17
   PubMed Web of Science ®Google Scholar
• Agu, P.C., Afiukwa, C.A., Orji, O.U., Ezeh, E.M., Ofoke, I.H., Ogbu, C.O., Ugwuja, E.I., Aja, P.M. (2023). Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci. Rep. 13(1): 13398. doi: 10.1038/s41598-023-40160-2
   PubMed Web of Science ®Google Scholar
• McConkey, B.J., Sobolev, V., Edelman, M. (2002). The performance of current methods in ligand–protein docking. Curr. Sci. 83(7): 845-856.
   Web of Science ®Google Scholar
• Kim, C., Mahasenan, K.V., Bhardwaj, A., Wiest, O., Chang, M., Mobashery, S. (2021). Production of proteins of the SARS-CoV-2 proteome for drug discovery. ACS Omega. 6(30): 19983-19994. doi: 10.1021/acsomega.1c02984
   PubMed Web of Science ®Google Scholar
• Hidayah, R.N., Nafisa, B.B., ‘Arifin, M.S., Santosaningsih, D., Muti’ah, R. (2022). Antiviral activitiy of curcumin, demethoxycurcumin, bisdemethoxycurcumin and cyclocurcumin compounds of Curcuma longa against NSP3 on SARS-CoV-2. Indones J. Cancer Chemoprevent. 13(3): 166-174. doi: 10.14499/indonesianjcanchemoprev13iss3pp166-174
   Google Scholar
• Anggakusuma, Colpitts, C.C., Schang, L.M., Rachmawati, H., Frentzen, A., Pfaender, S., Behrendt, P., Brown, R.J.P., Bankwitz, D., Steinmann, J., Ott, M., Meuleman, P., Rice, C.M., Ploss, A., Pietschmann, T., Steinmann, E. (2014). Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. 63(7): 1137-1149. doi: 10.1136/gutjnl-2012-304299
   PubMed Web of Science ®Google Scholar
• Mounce, B.C., Cesaro, T., Carrau, L., Vallet, T., Vignuzzi, M. (2017). Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. Antiviral Res. 142:148-157. doi: 10.1016/j.antiviral.2017.03.014
   PubMed Web of Science ®Google Scholar
• Liao, Q., Qian, Z., Liu, R., An, L., Chen, X. (2013). Germacrone inhibits early stages of influenza virus infection. Antiviral Res. 100(3): 578-588. doi: 10.1016/j.antiviral.2013.09.021
   PubMed Web of Science ®Google Scholar
• Chen, Y., Dong, Y., Jiao, Y., Hou, L., Shi, Y., Gu, T., Zhou, P., Shi, Z., Xu, L., Wang, C. (2015). In vitro antiviral activity of germacrone against porcine parvovirus. Arch. Virol. 160(6): 1415-1420. doi: 10.1007/s00705-015-2393-3
   PubMed Web of Science ®Google Scholar
• Nor Azman, N.S., Hossan, M.S., Nissapatorn, V., Uthaipibull, C., Prommana, P., Jin, K.T., Rahmatullah, M., Mahboob, T., Raju, C.S., Jindal, H.M., Hazra, B., Razak, R.M.M.A, Prajapati, V.K., Pandey, R.K., Aminudin, N., Shaari, K., Ismail, N.H., Butler, M.S., Zarubaev, V.V., Wiart, C. (2018). Anti-infective activities of 11 plants species used in traditional medicine in Malaysia. Exp. Parasitol. 194: 67-78. doi: 10.1016/j.exppara.2018.09.020
   PubMed Web of Science ®Google Scholar